z-logo
open-access-imgOpen Access
Fat-free mass index in patients with chronic obstructive pulmonary disease
Author(s) -
R A Díaz-Sanabria,
Clara Helena González-Correa,
Felipe Marulanda-Mejía,
C D Aguilar-Díaz,
Luz Elena Sepúlveda-Gallego,
Laura Duque-González,
M C Pineda Zuluaga
Publication year - 2021
Publication title -
journal of physics. conference series
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 85
eISSN - 1742-6596
pISSN - 1742-6588
DOI - 10.1088/1742-6596/2008/1/012010
Subject(s) - medicine , copd , body mass index , cardiology , pulmonary function testing , mass index , obstructive lung disease , pulmonary disease , correlation , physical therapy , prospective cohort study , disease , geometry , mathematics
Chronic Obstructive Pulmonary Disease (COPD) is a public health problem because it is a major cause of death in the world. Approximately 25% of patients with moderate disease and 35% with severe disease show a reduced fat-free mass (FFM). Thus, the objective of this study is to define the correlation between fat-free mass index (FFMI), muscle function, respiratory symptoms, number of exacerbations during the last year, and degree of airflow obstruction in patients with COPD. It is a prospective and cross-sectional study. The FFMI was below 32.7% (n=18) and the strength diminished by 56.4% (n=31). In the sample, we found a direct and significant correlation between the FFMI and the FEV1 (predicted %), (p= 0.045). When analysed by sex, men had a direct correlation between FFMI and the FEV1 (predicted %), (p=0.019), an inverse correlation between FFMI and the spirometric classification of the Global Initiative Obstructive Lung Disease (GOLD) (p=0.008), and between the muscular function and the symptoms (p=0.03). In women, no significant correlation was found. In conclusion, the conditions in mass and muscular function were correlated with clinical variables and pulmonary function in men. We did not find a correlation between corporal composition and the number of exacerbations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here